Daniel Spasic

Board member and acting Chief Executive Officer

Daniel Spasic started his career in the pharmaceutical industry in 1993 by joining Pharmacia and Upjohn in Lund, Sweden. He served in the Medical Department working with clinical development mainly in therapeutic areas such as CNS and oncology. In 1996, he founded TFS Trial Form Support a clinical contract research organisation (CRO) with a strong and dedicated focus in the area of clinical trials from phase I, II, III and IV. Under his guidance, TFS has become the leading clinical CRO in Europe serving pharmaceutical/ biotechnological, medical device and diagnostic companies in their clinical drug development process. He is an active member of the Drug Information Association (DIA), SwedenBio and Medicon Valley Alliance. He is also a member of the Board of Medicon Valley Alliance - one of the strongest bioregions in Europe. Daniel holds a technical degree in chemical engineering.

Back to TFS Board of Directors